These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23953408)

  • 1. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.
    Mukesh MB; Harris E; Collette S; Coles CE; Bartelink H; Wilkinson J; Evans PM; Graham P; Haviland J; Poortmans P; Yarnold J; Jena R
    Radiother Oncol; 2013 Aug; 108(2):293-8. PubMed ID: 23953408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability of fibrosis in radiotherapy of breast cancer: accelerated partial breast irradiation vs conventional external-beam radiotherapy.
    Jothy Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
    J Cancer Res Ther; 2008; 4(3):126-30. PubMed ID: 18923205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Laenen A; Petillion S; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2018 Jul; 57(7):916-923. PubMed ID: 29652212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.
    Hammer C; Maduro JH; Bantema-Joppe EJ; van der Schaaf A; van der Laan HP; Langendijk JA; Crijns AP
    Radiother Oncol; 2017 Jan; 122(1):45-49. PubMed ID: 27793444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation.
    Avanzo M; Stancanello J; Trovò M; Jena R; Roncadin M; Trovò MG; Capra E
    Phys Med; 2012 Oct; 28(4):296-306. PubMed ID: 22119271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying patients who are unsuitable for accelerated partial breast irradiation using three-dimensional external beam conformal techniques.
    Shikama N; Nakamura N; Kunishima N; Hatanaka S; Sekiguchi K
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e313-8. PubMed ID: 22417799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
    ; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
    Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
    Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment.
    Al Uwini S; Antonini N; Poortmans PM; Boersma L; Hurkmans C; Leer JW; Horiot JC; Struikmans H; Bartelink H
    Radiother Oncol; 2009 Oct; 93(1):87-93. PubMed ID: 19515444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study].
    Bourgier C; Pichenot C; Verstraet R; Heymann S; Biron B; Balleyguier C; Delaloge S; Mathieu MC; Uzan C; Garbay JR; Bourhis J; Taghian A; Marsiglia H
    Cancer Radiother; 2010 Dec; 14(8):718-26. PubMed ID: 20674444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.
    Jaikuna T; Osorio EV; Azria D; Chang-Claude J; De Santis MC; Gutiérrez-Enríquez S; van Herk M; Hoskin P; Lambrecht M; Lingard Z; Seibold P; Seoane A; Sperk E; Symonds RP; Talbot CJ; Rancati T; Rattay T; Reyes V; Rosenstein BS; de Ruysscher D; Vega A; Veldeman L; Webb A; West CML; Aznar MC
    Breast; 2023 Dec; 72():103578. PubMed ID: 37713940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial.
    Bourgier C; Acevedo-Henao C; Dunant A; Rossier C; Levy A; El Nemr M; Dumas I; Delaloge S; Mathieu MC; Garbay JR; Taghian A; Marsiglia H
    Radiat Oncol; 2012 Aug; 7():141. PubMed ID: 22913640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
    Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.
    Bergom C; Kelly T; Morrow N; Wilson JF; Walker A; Xiang Q; Ahn KW; White J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):821-8. PubMed ID: 22208973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.